title: Reply: Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine.
authors.forename: Sheena
authors.initials: S
authors.lastname: Aurora
authors.forename: Hans-Christoph
authors.initials: HC
authors.lastname: Diener
authors.forename: David
authors.initials: D
authors.lastname: Dodick
mesh_terms: D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D009465:Neuromuscular Agents / Q000008:administration & dosage*
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A